Century Therapeutics, Inc. Debt Securities Available For Sale Excluding Accrued Interest
Century Therapeutics, Inc. (IPSC) had Debt Securities Available For Sale Excluding Accrued Interest of $147.55 million as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Balance Sheet › Assets
us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest · last filed 2026-08-12
- 2026-06-30: Debt Securities Available For Sale Excluding Accrued Interest $147.55M.
- 2026-03-31: Debt Securities Available For Sale Excluding Accrued Interest $165.92M.
- 2025-12-31: Debt Securities Available For Sale Excluding Accrued Interest $55.26M.
- 2025-09-30: Debt Securities Available For Sale Excluding Accrued Interest $77.23M.
| Period end | Debt Securities Available For Sale Excluding Accrued Interest |
|---|---|
| 2026-06-30 | $147.55M 10-Q · filed 2026-08-12 |
| 2026-03-31 | $165.92M 10-Q · filed 2026-05-13 |
| 2025-12-31 | $55.26M 10-Q · filed 2026-08-12 |
| 2025-09-30 | $77.23M 10-Q · filed 2025-11-13 |
| 2025-06-30 | $101.66M 10-Q · filed 2025-08-14 |
| 2025-03-31 | $133.97M 10-Q · filed 2025-05-15 |
| 2024-12-31 | $161.67M 10-K · filed 2026-03-12 |
| 2024-09-30 | $192.08M 10-Q · filed 2024-11-05 |
| 2024-06-30 | $228.17M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $203.06M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $214.51M 10-K · filed 2025-03-19 |
| 2023-09-30 | $230.50M 10-Q · filed 2023-11-09 |
| 2022-12-31 | $283.08M 10-K · filed 2024-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SAB Biotherapeutics, Inc. (SABS) | United States | $0.306B | -25.49 |
| X4 Pharmaceuticals, Inc (XFOR) | United States | $0.297B | -4.99 |
| Inhibikase Therapeutics, Inc. (IKT) | United States | $0.296B | -4.44 |
| Liminatus Pharma, Inc. (LIMN) | United States | $0.282B | |
| FATE THERAPEUTICS INC (FATE) | United States | $0.280B | -2.51 |
| Lexeo Therapeutics, Inc. (LXEO) | United States | $0.278B | -4.19 |
| PALISADE BIO, INC. (PALI) | United States | $0.275B | -11.41 |
| Invivyd, Inc. (IVVD) | United States | $0.270B | -2.42 |
| Ocugen, Inc. (OCGN) | United States | $0.343B | -6.34 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |